Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
RMD Open
|
November 30, 2018
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
JAMA Neurology
|
February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
Natacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
Natacha Madelon, Kim Lauper, Gautier Breville, et al.
RMD Open
|
June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry
Annik Steimer, Andrea Götschi, Jonas Brändli, et al.
Frontiers in Immunology
|
October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases
Catherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
RMD Open
|
June 12, 2024
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey
Pierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, et al.
Annals of the Rheumatic Diseases
|
May 7, 2018
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration
Kim Lauper, Dan C Nordström, Karel Pavelka, et al.
Seminars in Arthritis and Rheumatism
|
July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
Rheumatology (Oxford, England)
|
May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database
Michele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Rheumatology (Oxford, England)
|
December 13, 2023
A potential role for chlamydial infection in rheumatoid arthritis development
Celine Lamacchia, Romain Aymon, Brian C Hattel, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
RMD Open
|
November 30, 2018
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
JAMA Neurology
|
February 25, 2022
Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
Natacha Madelon, Nelli Heikkilä, Irène Sabater Royo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 18, 2021
Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
Natacha Madelon, Kim Lauper, Gautier Breville, et al.
RMD Open
|
June 23, 2026
Site-specific articular responses to b/tsDMARDs in rheumatoid arthritis: a longitudinal observational study from the Swiss Clinical Quality Management Registry
Annik Steimer, Andrea Götschi, Jonas Brändli, et al.
Frontiers in Immunology
|
October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases
Catherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
RMD Open
|
June 12, 2024
Evaluating the participation of junior members and patient and healthcare professionals representatives in EULAR task forces: results from an international survey
Pierre-Antoine Juge, Tue Wenzel Kragstrup, Luis Fernando Perez-Garcia, et al.
Annals of the Rheumatic Diseases
|
May 7, 2018
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration
Kim Lauper, Dan C Nordström, Karel Pavelka, et al.
Seminars in Arthritis and Rheumatism
|
July 9, 2019
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis
Kim Lauper, Denis Mongin, Florenzo Iannone, et al.
Rheumatology (Oxford, England)
|
May 14, 2021
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database
Michele Iudici, Matthias Jarlborg, Kim Lauper, et al.
Rheumatology (Oxford, England)
|
December 13, 2023
A potential role for chlamydial infection in rheumatoid arthritis development
Celine Lamacchia, Romain Aymon, Brian C Hattel, et al.
Page
of 7